Affiliation:
1. Department of Medicine, McMaster University and
2. Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
Abstract
Abstract
Assisted reproductive technology is widely used to treat couples affected by infertility. Complications associated with assisted reproduction include venous thromboembolism, ovarian hyperstimulation syndrome, and recurrent implantation failure. It has also been proposed that thrombophilia may be associated with an increased likelihood of these events. Although data are limited, antithrombotic therapy is frequently used to enhance the likelihood of successful assisted reproduction. This chapter reviews the risks of venous and arterial thromboembolism associated with assisted reproduction, as well as available data regarding the impact of thrombophilia on the risks of thromboembolism and failure of implantation. The role of antithrombotic therapy in reducing the likelihood of these events, along with recommendations from various guidelines, are also discussed.
Publisher
American Society of Hematology
Reference51 articles.
1. Heparin for assisted reproduction (review);Akhtar;Cochr Database Syst Rev,2013
2. Selective single blastocyst transfer reduces the multiple pregnancy rate and increases pregnancy rates: a pre-and postintervention study;Khalaf;BJOG,2008
3. Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis;Gelbaya;Human Reprod Update,2007
4. Canadian Fertility and Andrology Society
Human Assisted Reproduction 2013 Live Birth Rates for Canada [Media Release, September 26, 2013]
Accessed April 15, 2014
Available from: http://www.cfas.ca/index.php?option=com_content&view=article&id=1205%3Alive-birth-rates-2013&catid=929%3Apress-releases&Itemid=460
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献